Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Vis graf over relationer


- Design of clinical trials according to Good Clinical Practice

- Work in lab: Cell culturing, flowcytometry

- Especially knowledge in malignant melanoma

Primære forskningsområder

Oncology: In more detail cancer immunotherapy: The use of a persons immune system to fight cancer; i.e. with monoclonal antibodies, cancer vaccines and T cell therapy. My main research area is to test safety, toxicity an clinical efficacy of peptide vaccines consisting of PD-L1 and IDO peptides in combination with the standard treatment Nivolumab (PD-1 blocking antibody) (first in patient with malignant melanoma, and hopefully expand to other cancer types).

Aktuel forskning

Clinical trial with the title: "Combination therapy with Nivolumab and PD-L1/IDO peptide vaccine to patients with metastatic melanoma. Inclusion of the first patient in March 2017.

Mulige interessekonflikter

No conflicts of interest

ID: 45659854